Ultragenyx Pharmaceutical in California seeks an Executive Director, CMC QA to provide strategic, operational, and technical quality leadership across biologics, small molecules, gene therapy, and ASO. You will lead a team of 8–12 professionals and ensure phase-appropriate quality
Role Summary BioMarin is seeking a highly motivated individual with drug product development experience—preferably in solid oral dosage forms to oversee drug product development and manufacturing activities. This role may be fulfilled as a subject matter
LAB OVERVIEW Dr. Lisa Ellerbys laboratory at the Buck Institute for Research on Aging investigates the molecular mechanisms underlying age-related neurodegenerative diseases and develops novel small molecule and protein therapeutics for brain aging. We employ a rich toolkit
Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered
Postdoctoral Researcher - Age Rejuvenation Screening & Data Analysis POSITION SUMMARY The Ellerby and Gerencser labs at the Buck Institute seek a Postdoctoral Researcher (PhD required) with expertise in microscopy-based image processing, machine vision, and data
About Technical Operations BioMarin’s Technical Operations group is responsible for creating our drugs for use in clinical trials and for scaling production of those drugs for the commercial market. These engineers, technicians, scientists and support staff
Position Summary The Executive Director, CMC QA will provide strategic, operational, and technical quality leadership across all Ultragenyx programs inclusive of biologics, small molecule, gene therapy, and ASO. This leader will oversee CMC QA responsibilities spanning program QA
Lab Overview Dr. Lisa Ellerbys laboratory at the Buck Institute for Research on Aging investigates the molecular mechanisms underlying age-related neurodegenerative diseases and develops novel small molecule and protein therapeutics for brain aging. We employ a rich toolkit
Company Overview BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a
Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered
The Buck Institute for Research on Aging in Novato, CA seeks a Postdoctoral Researcher to lead an HTS program focused on brain aging and neurodegeneration. The successful candidate will develop screens to identify small molecules that reverse aging
Executive Director, CMC QA Novato, CA; South San Francisco, CA Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs
Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered